Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 76282-664

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 76282-664). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Sevelamer Carbonate Tabs 800mg)

Label for Sevelamer Carbonate Tablets, 800 mg, film coated, oral dosage form. The label shows the product name, strength in a highlighted yellow box, and manufacturer name Exelan Pharmaceuticals Inc. It indicates a package size of 270 film coated tablets and includes typical drug information such as inactive ingredients and storage instructions.*

FDA Label Image

Chemical Structure/figure 1 (Sevelamer Carbonate Tabs Fig01)

Chemical structure diagram illustrating the polymeric composition of sevelamer carbonate, showing repeating units with ammonium, bicarbonate, amine groups, and hydroxyl groups consistent with the sevelamer carbonate active ingredient.*

FDA Label Image

Figure 2 (Sevelamer Carbonate Tabs Fig02)

A forest plot showing the mean difference in outcomes between Sevelamer carbonate and placebo across various subgroups including screening BSA, baseline serum phosphorus levels, age, and dialysis status. The plot displays point estimates with 95% confidence intervals and labels subgroups with sample sizes and percentages.*

FDA Label Image

Figure 3 (Sevelamer Carbonate Tabs Fig03)

A line graph depicting the percentage of patients with a reduction in serum phosphorus levels by 1 mg/dL or more. The x-axis shows reduction in serum phosphorus (mg/dL) from -4 to 8, while the y-axis shows the percentage of patients from 0 to 100%. Two lines are plotted: one for Sevelamer Hydrochloride and another for Active Control, illustrating their comparative effects on serum phosphorus levels.*

FDA Label Image

Sevelamer Carbonate Tabs Fig04

Line graph showing phosphorus change from baseline over 52 study weeks comparing Sevelamer Hydrochloride and an active control. The x-axis represents study weeks from 0 to 52, and the y-axis shows phosphorus change from baseline, ranging from -5 to 2. The graph includes two lines, one with black circles for Sevelamer Hydrochloride and one with red squares for active control, illustrating trends in phosphorus levels over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.